98 related articles for article (PubMed ID: 21636276)
21. Iminoheterocycles as gamma-secretase modulators.
Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
[TBL] [Abstract][Full Text] [Related]
22. Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.
Portelius E; Van Broeck B; Andreasson U; Gustavsson MK; Mercken M; Zetterberg H; Borghys H; Blennow K
J Alzheimers Dis; 2010; 21(3):1005-12. PubMed ID: 20634579
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme.
Rynearson KD; Buckle RN; Barnes KD; Herr RJ; Mayhew NJ; Paquette WD; Sakwa SA; Nguyen PD; Johnson G; Tanzi RE; Wagner SL
Bioorg Med Chem Lett; 2016 Aug; 26(16):3928-37. PubMed ID: 27426299
[TBL] [Abstract][Full Text] [Related]
24. Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.
Sun ZY; Asberom T; Bara T; Bennett C; Burnett D; Chu I; Clader J; Cohen-Williams M; Cole D; Czarniecki M; Durkin J; Gallo G; Greenlee W; Josien H; Huang X; Hyde L; Jones N; Kazakevich I; Li H; Liu X; Lee J; Maccoss M; Mandal MB; McCracken T; Nomeir A; Mazzola R; Palani A; Parker EM; Pissarnitski DA; Qin J; Song L; Terracina G; Vicarel M; Voigt J; Xu R; Zhang L; Zhang Q; Zhao Z; Zhu X; Zhu Z
J Med Chem; 2012 Jan; 55(1):489-502. PubMed ID: 22098494
[TBL] [Abstract][Full Text] [Related]
25. γ-Secretase component presenilin is important for microglia β-amyloid clearance.
Farfara D; Trudler D; Segev-Amzaleg N; Galron R; Stein R; Frenkel D
Ann Neurol; 2011 Jan; 69(1):170-80. PubMed ID: 21280087
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
27. Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activity.
Keown LE; Collins I; Cooper LC; Harrison T; Madin A; Mistry J; Reilly M; Shaimi M; Welch CJ; Clarke EE; Lewis HD; Wrigley JD; Best JD; Murray F; Shearman MS
J Med Chem; 2009 Jun; 52(11):3441-4. PubMed ID: 19432431
[TBL] [Abstract][Full Text] [Related]
28. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
Gerlach K; Hobson S; Eickmeier C; Groß U; Braun C; Sieger P; Garneau M; Hoerer S; Heine N
Bioorg Med Chem; 2018 Jul; 26(12):3227-3241. PubMed ID: 29735425
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II does not directly affect Aβ secretion or β-/γ-secretase activity via activation of angiotensin II type 1 receptor.
Wang BR; Shi JQ; Zhang YD; Zhu DL; Shi JP
Neurosci Lett; 2011 Aug; 500(2):103-7. PubMed ID: 21704122
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
[TBL] [Abstract][Full Text] [Related]
31. A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage.
Lai MT; Crouthamel MC; DiMuzio J; Pietrak BL; Donoviel DB; Bernstein A; Gardell SJ; Li YM; Hazuda D
J Neurochem; 2006 Jan; 96(1):118-25. PubMed ID: 16300640
[TBL] [Abstract][Full Text] [Related]
32. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.
Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H
Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235
[TBL] [Abstract][Full Text] [Related]
33. Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.
Qin J; Dhondi P; Huang X; Mandal M; Zhao Z; Pissarnitski D; Zhou W; Aslanian R; Zhu Z; Greenlee W; Clader J; Zhang L; Cohen-Williams M; Jones N; Hyde L; Palani A
Bioorg Med Chem Lett; 2011 Jan; 21(2):664-9. PubMed ID: 21195610
[TBL] [Abstract][Full Text] [Related]
34. Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats.
Takahashi H; Fukumoto H; Maeda R; Terauchi J; Kato K; Miyamoto M
Brain Res; 2010 Nov; 1361():146-56. PubMed ID: 20849831
[TBL] [Abstract][Full Text] [Related]
35. Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors.
Wu WL; Asberom T; Bara T; Bennett C; Burnett DA; Clader J; Domalski M; Greenlee WJ; Josien H; McBriar M; Rajagopalan M; Vicarel M; Xu R; Hyde LA; Del Vecchio RA; Cohen-Williams ME; Song L; Lee J; Terracina G; Zhang Q; Nomeir A; Parker EM; Zhang L
Bioorg Med Chem Lett; 2013 Feb; 23(3):844-9. PubMed ID: 23265892
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
[TBL] [Abstract][Full Text] [Related]
37. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
[TBL] [Abstract][Full Text] [Related]
38. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
[TBL] [Abstract][Full Text] [Related]
40. Modeling effect of a γ-secretase inhibitor on amyloid-β dynamics reveals significant role of an amyloid clearance mechanism.
Das R; Nachbar RB; Edelstein-Keshet L; Saltzman JS; Wiener MC; Bagchi A; Bailey J; Coombs D; Simon AJ; Hargreaves RJ; Cook JJ
Bull Math Biol; 2011 Jan; 73(1):230-47. PubMed ID: 20411345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
